Literature DB >> 30371519

Acute Phase Response in Critically Ill Elderly Burn Patients.

Sarah Rehou1,2, Shahriar Shahrokhi1,3, Joanne Thai2, Mile Stanojcic2,4, Marc G Jeschke.   

Abstract

OBJECTIVES: Survival of elderly burn patients remains unacceptably poor. The acute phase, defined as the first 96 hours after burn, includes the resuscitation period and influences subsequent outcomes and survival. The aim of this study was to determine if the acute phase response post burn injury is significantly different in elderly patients compared with adult patients and to identify elements contributing to adverse outcomes.
DESIGN: Cohort study.
SETTING: Tertiary burn center. PATIENTS: Adult (< 65 yr old) and elderly (≥ 65 yr old) patients with an acute burn injury.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: We included all patients with an acute burn injury greater than or equal to 20% total body surface area to our burn center from 2011 to 2016. Clinical and laboratory measures during the acute phase were compared between adult and elderly patients. Outcomes included clinical hemodynamic measurements, organ biomarkers, volume of fluid resuscitation, cardiac agents, and the inflammatory cytokine response in plasma. Data were analyzed using the Student t test, Mann-Whitney U test, and Fisher exact test. A total of 149 patients were included, with 126 adults and 23 elderly. Injury severity was not significantly different among adult and elderly patients. Elderly had significantly lower heart rates (p < 0.05), cardiac index (p < 0.05), mean arterial pressure (p < 0.05), PaO2/FIO2 (p < 0.05), and pH (p < 0.05), along with higher lactate (p < 0.05). Organ biomarkers, particularly creatinine and blood urea nitrogen, showed distinct differences between adults and elderly (p < 0.05). Elderly had significantly lower levels of interleukin-6, monocyte chemotactic protein-1, monocyte chemotactic protein-3, and granulocyte-colony stimulating factor during the acute phase (p < 0.05). Overall mortality was significantly higher in elderly patients (5% vs 52%; p < 0.0001).
CONCLUSIONS: Response to the burn injury during the acute phase response after burn is substantially different between elderly and adult burn patients and is characterized by cardiac depression and hypoinflammation.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30371519     DOI: 10.1097/CCM.0000000000003516

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  6 in total

Review 1.  Burn injury.

Authors:  Marc G Jeschke; Margriet E van Baar; Mashkoor A Choudhry; Kevin K Chung; Nicole S Gibran; Sarvesh Logsetty
Journal:  Nat Rev Dis Primers       Date:  2020-02-13       Impact factor: 52.329

2.  The prognostic nutritional index on postoperative day one is associated with one-year mortality after burn surgery in elderly patients.

Authors:  Young Joo Seo; Yu-Gyeong Kong; Jihion Yu; Ji Hyun Park; Su-Jin Kim; Hee Yeong Kim; Young-Kug Kim
Journal:  Burns Trauma       Date:  2021-03-01

3.  Impairment of μ-calpain activation by rhTNFR:Fc reduces severe burn-induced membrane disruption in the heart.

Authors:  Meng-Shu Cao; Ting-Yan Zhao; Zhi-Long Song; Hong-Ting Lu; Yun Zheng; Xiao-Ming Gu; Tao Lu; Qiong Wang; Jing-Jun Zhou
Journal:  Cell Death Discov       Date:  2022-01-10

4.  Epidemiological Investigation of Elderly Patients with Severe Burns at a Major Burn Center in Southwest China.

Authors:  Wensheng Wang; Junhui Zhang; Yanling Lv; Peng Zhang; Yuesheng Huang; Fei Xiang
Journal:  Med Sci Monit       Date:  2020-01-06

5.  Genome-wide comparisons of gene expression in adult versus elderly burn patients.

Authors:  Stephanie C Dreckmann; Saeid Amini-Nik; Ronald G Tompkins; Miliana Vojvodic; Marc G Jeschke
Journal:  PLoS One       Date:  2019-12-13       Impact factor: 3.240

6.  Adipose browning response to burn trauma is impaired with aging.

Authors:  Abdikarim Abdullahi; Carly M Knuth; Christopher Auger; Thibacg Sivayoganathan; Alexandra Parousis; Marc G Jeschke
Journal:  JCI Insight       Date:  2021-08-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.